APA (7th ed.) Citation

SAGEN, J. V., RAEDER, H., GLOYN, A. L., HATTERSLEY, A. T., MOLVEN, A., SØVIK, O., . . . BELL, G. I. (2004). Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: Patient characteristics and initial response to sulfonylurea therapy. Diabetes (New York, N.Y.), 53(10), 2713-2718. https://doi.org/10.2337/diabetes.53.10.2713

Chicago Style (17th ed.) Citation

SAGEN, Jørn V., et al. "Permanent Neonatal Diabetes Due to Mutations in KCNJ11 Encoding Kir6.2: Patient Characteristics and Initial Response to Sulfonylurea Therapy." Diabetes (New York, N.Y.) 53, no. 10 (2004): 2713-2718. https://doi.org/10.2337/diabetes.53.10.2713.

MLA (9th ed.) Citation

SAGEN, Jørn V., et al. "Permanent Neonatal Diabetes Due to Mutations in KCNJ11 Encoding Kir6.2: Patient Characteristics and Initial Response to Sulfonylurea Therapy." Diabetes (New York, N.Y.), vol. 53, no. 10, 2004, pp. 2713-2718, https://doi.org/10.2337/diabetes.53.10.2713.